Published in J Lipid Res on September 16, 2003
A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest (2005) 3.44
Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron (2004) 3.21
Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu Rev Nutr (2011) 1.88
Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke (2009) 1.62
Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1. J Lipid Res (2010) 1.45
Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. J Lipid Res (2008) 1.36
Neurolipidomics: challenges and developments. Front Biosci (2007) 1.29
Lipids and lipidomics in brain injury and diseases. AAPS J (2006) 1.27
Cyclooxygenase-2 in synaptic signaling. Curr Pharm Des (2008) 1.26
Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death. J Neurol Sci (2009) 1.26
Docosahexaenoic acid and the aging brain. J Nutr (2008) 1.20
Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. J Neuroinflammation (2006) 1.20
Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc Natl Acad Sci U S A (2004) 1.20
Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins Leukot Essent Fatty Acids (2009) 1.19
Dietary manipulation implicates lipid signaling in the regulation of germ cell maintenance in C. elegans. Dev Biol (2006) 1.17
Docosahexaenoic acid signaling modulates cell survival in experimental ischemic stroke penumbra and initiates long-term repair in young and aged rats. PLoS One (2012) 1.14
Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disorders. Neurochem Res (2005) 1.12
Abundance of triacylglycerols in ganglia and their depletion in diabetic mice: implications for the role of altered triacylglycerols in diabetic neuropathy. J Neurochem (2006) 1.10
Resolvins: natural agonists for resolution of pulmonary inflammation. Prog Lipid Res (2010) 1.08
The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid neuroprotective signaling. Cell Mol Neurobiol (2006) 1.06
Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model. PLoS One (2007) 1.06
Exercise contributes to the effects of DHA dietary supplementation by acting on membrane-related synaptic systems. Brain Res (2009) 1.04
Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity. Mol Neurobiol (2011) 1.03
Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor. J Neurochem (2008) 1.02
Resolution of inflammation in asthma. Clin Chest Med (2012) 1.02
Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism. Biochemistry (2006) 1.00
Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia. Curr Opin Clin Nutr Metab Care (2011) 0.98
Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission. Prostaglandins Other Lipid Mediat (2011) 0.95
Docosahexaenoic acid neurolipidomics. Prostaglandins Other Lipid Mediat (2009) 0.95
Tranylcypromine: new perspectives on an "old" drug. Eur Arch Psychiatry Clin Neurosci (2006) 0.93
Sphingolipids in multiple sclerosis. Neuromolecular Med (2010) 0.93
Docosahexaenoic acid confers enduring neuroprotection in experimental stroke. J Neurol Sci (2013) 0.90
Dual roles of brain serine hydrolase KIAA1363 in ether lipid metabolism and organophosphate detoxification. Toxicol Appl Pharmacol (2007) 0.89
Catalytic nanoceria are preferentially retained in the rat retina and are not cytotoxic after intravitreal injection. PLoS One (2013) 0.88
Docosahexaenoic acid production and lipid-body formation in Schizochytrium limacinum SR21. Mar Biotechnol (NY) (2006) 0.88
Docosahexaenoic acid complexed to human albumin in experimental stroke: neuroprotective efficacy with a wide therapeutic window. Exp Transl Stroke Med (2012) 0.86
Acute treatment with docosahexaenoic acid complexed to albumin reduces injury after a permanent focal cerebral ischemia in rats. PLoS One (2013) 0.85
Cytosolic phospholipase A(2) alpha mediates electrophysiologic responses of hippocampal pyramidal neurons to neurotoxic NMDA treatment. Proc Natl Acad Sci U S A (2007) 0.83
LAU-0901, a novel platelet-activating factor receptor antagonist, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat. Brain Res (2008) 0.82
Modulation of T-type calcium channels by bioactive lipids. Pflugers Arch (2014) 0.81
Docosahexaenoic acid complexed to albumin provides neuroprotection after experimental stroke in aged rats. Neurobiol Dis (2013) 0.81
Retinoid X receptor activation is essential for docosahexaenoic acid protection of retina photoreceptors. J Lipid Res (2013) 0.81
LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia. Exp Neurol (2008) 0.81
Effect of acute administration of Pistacia lentiscus L. essential oil on rat cerebral cortex following transient bilateral common carotid artery occlusion. Lipids Health Dis (2012) 0.81
DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol (2015) 0.80
Chronic dietary n-6 PUFA deprivation leads to conservation of arachidonic acid and more rapid loss of DHA in rat brain phospholipids. J Lipid Res (2014) 0.80
Lipid-mediated cell signaling protects against injury and neurodegeneration. J Nutr (2010) 0.80
Expression and induction of secretory phospholipase A2 group IB in brain. Cell Mol Neurobiol (2005) 0.79
Regional changes in CNS and retinal glycerophospholipid profiles with age: a molecular blueprint. J Lipid Res (2017) 0.76
5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone. Pflugers Arch (2013) 0.75
Lissencephaly, IgG subclass immunodeficiency, and a connective tissue disorder: a new syndrome? J Neurol (2009) 0.75